Old Web
English
Sign In
Acemap
>
Paper
>
Selecting new upfront regimens for advanced ovarian cancer with biomarker guidance
Selecting new upfront regimens for advanced ovarian cancer with biomarker guidance
2020
John K. C. Chan
Su-Ying Liang
Daniel S. Kapp
Joshua E. Chan
Thomas J. Herzog
Robert L. Coleman
Bradley J. Monk
Michael T. Richardson
Keywords:
Maintenance therapy
Poly (ADP-Ribose) Polymerase Inhibitor
Biomarker (medicine)
advanced ovarian cancer
Oncology
Medicine
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
10
References
1
Citations
NaN
KQI
[]